Company: CSTL
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001447362-25-000031
Chunk: 20

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-02-27
Form: 10-K
Item: Item 7
Chunk 20
---
 were marketed before May 6, 2024.

Delivered Test Reports

The number of test reports we deliver is a key indicator that we use to assess our business. A test report is generated when we receive a sample in our laboratory, and then the relevant test information is entered into our Laboratory Information Management System, the laboratory portion of the test is performed, including proprietary algorithmic analysis of the combined biomarkers and a report is then delivered to the clinician who ordered the test.

The number of test reports delivered by us during the years ended December 31, 2024 and 2023 are presented in the table below:

Proprietary Dermatologic GEP Tests DecisionDx-MelanomaDecisionDx-SCCDiagnostic GEP offering (1)Dermatologic TotalDecisionDx-UMTissueCypher(2)IDgenetix(3)Grand TotalQ1 20248,384 3,577 998 12,959 422 3,429 4,078 20,888 Q2 20249,585 4,277 1,099 14,961 456 4,782 4,903 25,102 Q3 20249,367 4,195 933 14,495 397 6,073 5,045 26,010 Q4 20248,672 4,299 879 13,850 424 6,672 3,125 24,071 For the year ended December 31, 202436,008 16,348 3,909 56,265 1,699 20,956 17,151 96,071 Q1 20237,583 2,411 980 10,974 409 1,383 2,150 14,916 Q2 20238,597 2,681 953 12,231 461 1,447 2,681 16,820 Q3 20238,559 2,820 1,011 12,390 399 2,829 2,791 18,409 Q4 20238,591 3,530 1,018 13,139 405 3,441 3,299 20,284 For the year ended December 31, 202333,330 11,442 3,962 48,